Immunovant, Inc.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fra…
Biotechnology
US, New York [HQ]
Financials
Earnings Call Transcripts
Earnings Call · Transcripts · SpeakersThis analysis tool shows transcript versions of the official earnings calls hosted by Immunovant, Inc.
Could not find a transcript
Peers Transcripts
Peers Analysis-
Sorry! None of IMVT's peers has listed transcripts.
Upcoming Transcript Tools
- Full Text Search - Across All Transcripts
- Detail Speaker Profiles
- Non-US Transcripts